The preferential targeting of the diseased microvasculature by disk-like particles
about
Targeted nanotechnology for cancer imaging.Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumorsConvergence of nanotechnology and cancer prevention: are we there yet?Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery SystemsGeneration of Shear Adhesion Map Using SynVivo Synthetic Microvascular NetworksHierarchically-Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor AccumulationA Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications.Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticlesLipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulationUSNCTAM perspectives on mechanics in medicine.Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle designMultistage vector (MSV) therapeutics.A Micro/Nano Composite for Combination Treatment of Melanoma Lung MetastasisNano- and microfabrication for overcoming drug delivery challenges.Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying PotentialHeterogeneity in nanoparticles influences biodistribution and targeting.Vascular deposition patterns for nanoparticles in an inflamed patient-specific arterial tree.Functionalised porous silicon as a biosensor: emphasis on monitoring cells in vivo and in vitro.Particle platforms for cancer immunotherapy.Nanooncology: the future of cancer diagnosis and therapy.In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases.Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.Strategies for improving drug delivery: nanocarriers and microenvironmental priming.Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers [WO2012042024].Post-nano strategies for drug delivery: Multistage porous silicon microvectors.An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles.Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activationActivation of the inflammasome and enhanced migration of microparticle-stimulated dendritic cells to the draining lymph node.Directed transport of bacteria-based drug delivery vehicles: bacterial chemotaxis dominates particle shape.Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy.Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.Microparticle shape effects on margination, near-wall dynamics and adhesion in a three-dimensional simulation of red blood cell suspension.Shape-mediated margination and demargination in flowing multicomponent suspensions of deformable capsules.Generation of Well-Defined Micro/Nanoparticles via Advanced Manufacturing Techniques for Therapeutic Delivery.
P2860
Q27010317-59BAA835-B4F2-44BC-B707-C388160DA52AQ27330421-56BD9E84-AA02-4A51-A528-B1CADA8479D8Q28386699-8D0A94E4-6980-4CE7-8C63-BF7D0FB9E534Q28553638-F3DFD391-F607-44A8-AAA6-7182EBE2F53CQ29028582-E1C84EE9-B92A-4ED9-8909-148B263ECC43Q30979863-10B258C8-948D-4ECF-A6AB-F58A24772CAFQ33677713-21554989-15B9-4CD4-A1FB-34A7DAE37516Q33755231-A34F25AE-874A-4C20-B990-3F58C2016F1EQ33831661-C9EF9158-F392-4B27-A12E-0D5A2DB898A6Q34030709-9C5B257F-C64C-43C0-AACD-09262429D647Q34270352-92F65644-5DF4-4B3F-8EDF-F352D7DABA8AQ34398830-CB53168A-E85B-468B-91F4-6664339BDAB2Q36279715-7F8490B9-29A5-4A9C-8FBF-12663A7AB530Q36307634-E8C7ACF1-3F2C-40EC-B19D-CC52318A8F3EQ36813889-BC94B60F-DB0B-4561-9EF3-B6D8719F83B2Q36882209-3DCAD2F1-9904-457A-B63C-E088655E0B36Q37436787-A5A05AA3-9E5D-437A-A800-268D3DE19D41Q37445335-B3A14EA8-DB23-459F-BB12-87500E8A4FE2Q37585668-C7AD480F-5B43-471F-980E-53FEF7C740CCQ38109013-3727FF6F-C516-4BB9-B44B-689E804E9340Q38114060-2331DBF8-A496-4150-B8A9-43D6B79F46FDQ38151549-ACB82FE2-39B4-47B2-953A-58DCDF0E6085Q38405765-4DD1E877-B5A8-42BB-A2EC-72035A067D72Q38847912-0FB55006-2099-4DF6-91F9-139C7DBC246EQ38957484-50DFBA8E-AB57-434A-BC37-2B6D4F9E8D50Q38968910-1F3E3373-281F-4667-9F23-63D0DB1A8167Q39199893-2E6AC2E8-E5D3-493A-8B44-0325DAAD43BCQ39290416-D5431495-52A3-4390-BFB3-D93A6D624DD8Q39410383-AA9CBE94-9DC0-421D-92DB-4885C69AD24CQ41495734-49DC87D9-F9AE-411F-8162-B3BED2AC6C7CQ41495742-01EFF248-92D8-4CD5-9097-BBF284F3DDA5Q42414596-6FDA305A-19F7-43C3-BC76-C6B57B032641Q44999082-8C113375-5999-4288-96D7-D053829272E9Q48236648-A8C171FC-73AB-45F0-9BBD-6EF05FB025BBQ49628457-4FA0CD71-5C3A-40D0-A25B-36A4E559A1DFQ50453339-A08B02EB-13D6-4B5F-9187-74FF5DDC6D82Q51602330-8F007C00-712A-4834-95DF-14C53F1D170FQ54994812-76E09AD2-402A-4378-9E02-42E9AC52A40E
P2860
The preferential targeting of the diseased microvasculature by disk-like particles
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The preferential targeting of the diseased microvasculature by disk-like particles
@ast
The preferential targeting of the diseased microvasculature by disk-like particles
@en
type
label
The preferential targeting of the diseased microvasculature by disk-like particles
@ast
The preferential targeting of the diseased microvasculature by disk-like particles
@en
prefLabel
The preferential targeting of the diseased microvasculature by disk-like particles
@ast
The preferential targeting of the diseased microvasculature by disk-like particles
@en
P2093
P2860
P50
P1433
P1476
The preferential targeting of the diseased microvasculature by disk-like particles
@en
P2093
Fazle Hussain
Mauro Ferrari
P2860
P304
P356
10.1016/J.BIOMATERIALS.2012.04.027
P577
2012-05-11T00:00:00Z